Articles by Disease (Bladder Cancer)

Cancer-Homing Toxins

Journal: Current Pharmaceutical Design
Volume: 8
Page: 1973-1985
Author(s): H. C. Ng and H. E. Khoo

Tissue Transport of Anti-cancer Drugs

Journal: Current Pharmaceutical Design
Volume: 8
Page: 1987-1993
Author(s): Jan Lankelma

ETS Proteins and MMPs: Partners in Invasion and Metastasis

Journal: Current Drug Targets
Volume: 3
Page: 359-367
Author(s): Sadmeet Singh, Jane Barrett, Kenji Sakata, Richard G. Tozer and Gurmit Singh

Trans-Platinum Complexes as Anticancer Drugs: Recent Developments and Future Prospects

Journal: Current Medicinal Chemistry
Volume: 9
Page: 1611-1618
Author(s): S. Radulovic, Z. Tesic and S. Manic

Immune Modulation by Ionizing Radiation and its Implications for Cancer Immunotherapy

Journal: Current Pharmaceutical Design
Volume: 8
Page: 1765-1780
Author(s): Eric J. Friedman

Influence of the Bystander Effect on HSV-tk / GCV Gene Therapy. A Review.

Journal: Current Gene Therapy
Volume: 2
Page: 307-322
Author(s): Ingrid J. van Dillen, Nanno H. Mulder, Willem Vaalburg, Erik F.J. de Vries and Geke A.P. Hospers

Transductional Targeting with Recombinant Adenovirus Vectors

Journal: Current Gene Therapy
Volume: 2
Page: 323-339
Author(s): Valerie Legrand, Philippe Leissner, Arend Winter, Majid Mehtali and Monika Lusky

The ‘Other’ Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 2
Page: 589-603
Author(s): L. A. Beltz

Targetin g Human Tel omerase by Antisens e Oligonucleotides and Ribozymes

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 2
Page: 605-612
Author(s): M. Folini, M. Pennati and N. Zaffaroni

How to Inhibit Telomerase Activity for Cancer Therapy

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 2
Page: 613-626
Author(s): Satoru Kyo and Masaki Inoue